CIESP

Time to deliver: report of the WHO Independent High-Level Commission on NCDs

S. Nishtar,S. Niinistö,M. Sirisena,T. Vázquez,V. Skvortsova,A. Rubinstein,F. G. Mogae,P. Mattila,S. H. Ghazizadeh Hashemi,S. Kariuki,J. Narro Robles,I. F. Adewole,A. D. Sarr,K. Y. Gan,S. M. Piukala,A. Al Owais,E. Hargan,G. Alleyne,A. Alwan,A. Bernaert,M. Bloomberg,K. Dain,T. Frieden,V. H. Patel,A. Kennedy and I. Kickbusch. Time to deliver: report of the WHO Independent High-Level Commission on NCDs. Lancet. 2018;392(10143):10.1016/s0140-6736(18)31258-3.

Time to deliver: report of the WHO Independent High-Level Commission on NCDs Ver más »

Theory-driven, rapid formative research on quality improvement intervention for critical care of patients with COVID-19 in Argentina

J. Roberti,F. Jorro,V. Rodríguez,M. Belizán,P. Arias,M. E. Ratto,R. Reina,N. Ini,C. Loudet and E. García-Elorrio. Theory-driven, rapid formative research on quality improvement intervention for critical care of patients with COVID-19 in Argentina. Glob Qual Nurs Res. 2021;8:10.1177/23333936211015660.

Theory-driven, rapid formative research on quality improvement intervention for critical care of patients with COVID-19 in Argentina Ver más »

The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries

F. Althabeand W. A. T. Collaborators. The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries. Trials. 2019;20(1):10.1186/s13063-019-3488-z.

The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries Ver más »

The Use of 2 e-Learning Modalities for Diabetes Education Using Facebook in 2 Cities of Argentina During the COVID-19 Pandemic: Qualitative Study

D. L. Moyano,M. V. Lopez,A. Cavallo,J. P. Candia,A. Kaen,V. Irazola and A. Beratarrechea. The Use of 2 e-Learning Modalities for Diabetes Education Using Facebook in 2 Cities of Argentina During the COVID-19 Pandemic: Qualitative Study. JMIR Form Res. 2022;6(11):10.2196/38862.

The Use of 2 e-Learning Modalities for Diabetes Education Using Facebook in 2 Cities of Argentina During the COVID-19 Pandemic: Qualitative Study Ver más »

The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review

A. Ciapponi,E. Tapia-López,S. Virgilio and A. Bardach. The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review. Syst Rev. 2020;9(1):10.1186/s13643-020-01404-8.

The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review Ver más »

The need for standardized reporting of research findings in the field of quality of care

E. García-Elorrioand S. Aziz. The need for standardized reporting of research findings in the field of quality of care. Int J Qual Health Care. 2021;33(1):10.1093/intqhc/mzab040.

The need for standardized reporting of research findings in the field of quality of care Ver más »

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk

D. Spiegelman,L. C. Lovato,P. Khudyakov,T. L. Wilkens,C. A. Adebamowo,S. N. Adebamowo,L. J. Appel,J. W. Beulens,J. W. Coughlin,L. O. Dragsted,H. J. Edenberg,J. N. Eriksen,R. Estruch,D. E. Grobbee,P. E. Gulayin,V. Irazola,J. H. Krystal,M. Lazo,M. M. Murray,E. B. Rimm,I. C. Schrieks,J. D. Williamson and K. J. Mukamal. The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk. Eur J Prev Cardiol. 2020;27(18):10.1177/2047487320912376.

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk Ver más »